Kevin Yee
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Chronic Myeloid Leukemia Treatments 6
- Acute Myeloid Leukemia Research 5
- Genetics 4
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- Michael C. HeinrichJulie M. CherringtonAjia TownBeverly D. SmolichLesley MurraySharianne G. LouieWilliam C. ManningLeslie B. Lee
- Journals
- Blood (4 papers)Human Mutation (1 paper)Bioorganic & Medicinal Chemistry (1 paper)Cell Cycle (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesGermanyPuerto Rico
In The Last Decade
Kevin Yee
12 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 67
- Hematology 499
- Genetics 267
- Gastroenterology 89
- Oncology 303
- Pulmonary and Respiratory Medicine 362
Countries citing papers authored by Kevin Yee
This map shows the geographic impact of Kevin Yee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Yee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Yee more than expected).
Fields of papers citing papers by Kevin Yee
This network shows the impact of papers produced by Kevin Yee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Yee. The network helps show where Kevin Yee may publish in the future.
Co-authors
The 25 scholars most cited alongside Kevin Yee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2020 | 6 | |
| 3 | 2009 | 32 | |
| 4 | 2006 | 36 | |
| 5 | 2004 | 59 | |
| 6 | 2004 | 103 | |
| 7 | 2003 | 55 | |
| 8 | SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo Hit paper breakdown → | 2003 | 703 |
| 9 | Cancers of the gallbladder and biliary ducts. | 2002 | 28 |
| 10 | 2002 | 140 | |
| 11 | 2000 | 3 | |
| 12 | 1999 | 31 |
About Kevin Yee
Kevin Yee is a scholar working on Hematology, Genetics, Pharmacology, Rheumatology and Endocrinology, Diabetes and Metabolism, having authored 12 papers that have together received 1.2k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (6 papers), Acute Myeloid Leukemia Research (5 papers), Chronic Lymphocytic Leukemia Research (2 papers), Eosinophilic Disorders and Syndromes (2 papers), Cystic Fibrosis Research Advances (2 papers), Neonatal Respiratory Health Research (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Hormonal Regulation and Hypertension (2 papers). The work is most often cited by research in Hematology (499 citations), Genetics (267 citations), Gastroenterology (89 citations), Oncology (303 citations) and Pulmonary and Respiratory Medicine (362 citations). Kevin Yee has collaborated with scholars based in United States, Germany and Puerto Rico. Frequent co-authors include Michael C. Heinrich, Julie M. Cherrington, Ajia Town, Beverly D. Smolich, Lesley Murray, Sharianne G. Louie, William C. Manning, Leslie B. Lee, Tinya J. Abrams and Laura McGreevey. Their work appears in journals such as Blood, Human Mutation, Bioorganic & Medicinal Chemistry, Cell Cycle and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.